Asia-Pacific Multiple Myeloma Treatment Market Value to Hit $2.8B by 2021

Tuesday, October 20, 2015

Source: European Pharmaceutical Review

The treatment market for multiple myeloma across the Asia-Pacific (APAC) countries of China, India, Japan, and Australia will rise in value from $1.7 billion in 2014 to $2.8 billion by 2021, according to business intelligence provider GBI Research.

View All News »